| human | Q5 |
| P1280 | CONOR.SI ID | 26291043 |
| P6178 | Dimensions author ID | 01013261561.88 |
| P496 | ORCID iD | 0000-0003-3638-4619 |
| P6556 | SICRIS researcher ID | 22646 |
| P214 | VIAF ID | 4842154441742135460007 |
| P27 | country of citizenship | Slovenia | Q215 |
| P69 | educated at | Biotechnical Faculty of Ljubljana | Q13566286 |
| P108 | employer | New York Stem Cell Foundation | Q7014732 |
| P734 | family name | Marolt | Q21491948 |
| Marolt | Q21491948 | ||
| Marolt | Q21491948 | ||
| P101 | field of work | biotechnology | Q7108 |
| P735 | given name | Darja | Q18227995 |
| Darja | Q18227995 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| Slovene | Q9063 | ||
| P106 | occupation | researcher | Q1650915 |
| molecular biologist | Q15839206 | ||
| P21 | sex or gender | female | Q6581072 |
| Q38093335 | Bioreactor engineering of stem cell environments |
| Q50476908 | Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors |
| Q33583461 | Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture |
| Q36240656 | Bone scaffold architecture modulates the development of mineralized bone matrix by human embryonic stem cells |
| Q33999454 | Bone tissue engineering with human stem cells |
| Q51142450 | Breaking ground on translational stem cell research. |
| Q33992658 | Cultivation of human bone-like tissue from pluripotent stem cell-derived osteogenic progenitors in perfusion bioreactors |
| Q35054489 | Derivation of two new human embryonic stem cell lines from nonviable human embryos |
| Q37024407 | Effects of chondrogenic and osteogenic regulatory factors on composite constructs grown using human mesenchymal stem cells, silk scaffolds and bioreactors |
| Q39354096 | Effects of pamidronate on human alveolar osteoblasts in vitro |
| Q37344841 | Engineered microenvironments for human stem cells |
| Q36001194 | Engineering bone tissue from human embryonic stem cells |
| Q36884199 | Engineering bone tissue substitutes from human induced pluripotent stem cells |
| Q28391832 | Engineering custom-designed osteochondral tissue grafts |
| Q47690616 | Growth and differentiation of alveolar bone cells in tissue-engineered constructs and monolayer cultures. |
| Q44108031 | Make no bones about it: cells could soon be reprogrammed to grow replacement bones? |
| Q38134206 | Modulating the biochemical and biophysical culture environment to enhance osteogenic differentiation and maturation of human pluripotent stem cell-derived mesenchymal progenitors |
| Q41820368 | Optimizing the medium perfusion rate in bone tissue engineering bioreactors |
| Q34162359 | Potential pathophysiological mechanisms in osteonecrosis of the jaw. |
| Q28541513 | Primary human alveolar bone cells isolated from tissue samples acquired at periodontal surgeries exhibit sustained proliferation and retain osteogenic phenotype during in vitro expansion |
| Q44029887 | Specific activation of the Bacillus quorum-sensing systems by isoprenylated pheromone variants. |
| Q38148755 | State of the art in stem cell research: human embryonic stem cells, induced pluripotent stem cells, and transdifferentiation. |
| Q35878691 | Synergistic effects of hypoxia and morphogenetic factors on early chondrogenic commitment of human embryonic stem cells in embryoid body culture |
| Q37347496 | Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance |
| Darja Marolt Presen | wikipedia |
Search more.